A lawyer for the employers predicts that discovery will show that collusion between drugmakers and PBMs had a significant impact on his clients' costs.
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It's up to the government to cut high U.S. drug prices.
A settlement between the drugmaker and insulin patients that would have capped patients' out-of-pocket insulin costs at $35 for 4 years has fallen apart, after an "unfavorable ruling" from the judge overseeing the case.
In a recent speech, President Biden overstated the average monthly cost that patients were paying prior to the Inflation Reduction Act: The out-of-pocket cost for insulin was $58 for a 30-day supply, says a HHS report.
"Finally, we beat Big Pharma," said President Joe Biden to U.S. Senator Bernie Sanders on Wednesday at a White House event to promote efforts to lower the cost of asthma inhalers and other health-care expenses.